Transparency in drug industry relationships
Pendleton, C.
Nursing Times 112(21-23): 16
2016
ISSN/ISBN: 0954-7762 PMID: 27396097 Document Number: 689356
Document emailed within 1 workday
Related Documents
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25Calin, A. 1987: Drugs and the relationships between university, industry and legislation Drugs under Experimental and Clinical Research 13(11): 685-687
1992: ASHP guidelines on pharmacists' relationships with industry American Journal of Hospital Pharmacy 49(1): 154
de Mol, B. 2010: Conflicts of interest in physician-industry relationships in innovative care Nederlands Tijdschrift Voor Geneeskunde 154: A1526
Blumenthal, D. 1992: Academic-industry relationships in the life sciences. Extent, consequences, and management JAMA 268(23): 3344-3349
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Salas, Sía.P.; Osorio F, M.; Vial C, P.; Rehbein V, A.María.; Salas A, C.; Beca I, J.Pablo. 2006: Conflicts of interest in clinical practice. Ethical analysis of some relationships with the pharmaceutical industry Revista Medica de Chile 134(12): 1576-1582
Bondurant, S. 1984: Some reflections on the relationships between universities and industry as they influence the evolution of the medical-industrial complex North Carolina Medical Journal 45(4): 235-236
Annertz, Mårten. 2004: Drug industry and bribes Lakartidningen 101(15-16): 1436
Hallager, K. 2004: Physicians and drug industry Ugeskrift for Laeger 166(21): 2069
Schwartz, H. 1981: Medical costs and the drug industry Medical Times 109(3): 21s-24s; 28s
Habel, L. 1989: A first in the drug industry--the underpinnings of a pill Nursing Quebec 9(2): 11
Amédée-Manesme, O. 2000: Strategic analysis and the drug industry Therapie 55(2): 313-317
Modestin, J. 1970: Psychotropic drug therapy and pharmaceutical industry Arzneimittel-Forschung 20(7): 877-879
Schacter, L.P.; Anderson, C.; Canetta, R.M.; Kelley, S.; Nicaise, C.; Onetto, N.; Rozencweig, M.; Smaldone, L.; Winograd, B. 1992: Drug discovery and development in the pharmaceutical industry Seminars in Oncology 19(6): 613-621
Ziegler, R. 2006: Benefits and risks of drug industry "sponsorship" Medizinische Monatsschrift für Pharmazeuten 29(5): 193-194
Geursen, R. 1996: The drug industry and research: status in Germany Zentralblatt für Chirurgie 121(7): 603-605
Personeus, G.R.; Ascione, P. 1981: Preparation and use of drug master files in the pharmaceutical industry Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 35(2): 63-69
Håkansson, J. 2003: "Others are influenced, not me!" Physicians are often not aware how manipulated they are by drug industry Lakartidningen 100(50): 4158-4159